Immunomedics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
Immunomedics Price Target Raised To $55 From $41 At Wells Fargo
Article By: The Fly
Monday, July 6, 2020 10:52 AM EDT
Wells Fargo analyst Jim Birchenough raised the firm's price target on Immunomedics to $55 from $41.
In this article: IMMU
Read
Week In Review: Qiming Venture Closes $1.1 Billion Fund For Healthcare/TMT Investments
Article By: ChinaBio® Today
Saturday, April 11, 2020 2:34 PM EDT
Qiming closed its seventh China-focused US dollar fund with $1.1 billion for early stage Healthcare and TMT investments. Currently, Qiming manages nine US dollar funds and five RMB funds, with $5.3 billion of assets under management.
In this article: IMMU Also: GSK, REGN, ZLAB
Read
Immunomedics Downgraded To Sell From Buy At Goldman Sachs
Article By: The Fly
Friday, April 3, 2020 9:04 AM EDT
Goldman Sachs analyst Paul Choi double downgraded Immunomedics to Sell from Buy with a price target of $5, down from $24.
In this article: IMMU
Read
5 Drug/Biotech Stocks Likely To Beat Q4 Earnings Estimates
Article By: Zacks Investment Research
Monday, February 17, 2020 10:34 AM EDT
The Medical sector has witnessed a fairly good run in this earnings cycle so far.
In this article: IMMU, CLVS, PRGO, VTVT, ETON Also: JNJ, GILD
Read
IMMU: Why This Biotech Could Go Crazy In 2019
Article By: TipRanks
Tuesday, August 28, 2018 4:30 PM EDT
It’s been a year of rapid-fire growth for IMMU. The stock has rocketed 51% in 2018 alone; and 103% in year-over-year growth. Momentum doesn’t seem to be trailing for the mid-cap company either.
In this article: IMMU Also: CELG
Read

PARTNER HEADLINES

Latest Tweets for $IMMU

No tweets yet!